Moreover, the protein, mRNA and activity of GSK3β are reduced in the postmortem brains of Schizophrenia patients, suggesting the involvement of GSK3β activity in the etiology of schizophrenia [42], [43]. Here, GSK3B is linked to schizophrenia.